- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biosynex (ALBIO)"Biosynex stock price live, this page displays EPA ALBIO stock exchange data. View the ALBIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biosynex real time stock price chart below.
What Is the Biosynex Stock Price Today?
The Biosynex stock price today is 2.550.
What Is the Stock Symbol for Biosynex?
The stock symbol for Biosynex is ""ALBIO.""
What Stock Exchange Does Biosynex Trade On?
Biosynex is listed and trades on the Paris stock exchange.
Is Biosynex a Good Stock to Buy?
Determining whether Biosynex—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALBIO quote. (ISIN: FR0011005933)"
What Is the Biosynex Stock Price Today?
The Biosynex stock price today is 2.550.
What Is the Stock Symbol for Biosynex?
The stock symbol for Biosynex is ""ALBIO.""
What Stock Exchange Does Biosynex Trade On?
Biosynex is listed and trades on the Paris stock exchange.
Is Biosynex a Good Stock to Buy?
Determining whether Biosynex—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALBIO quote. (ISIN: FR0011005933)"
Paris
Currency in EUR
2.550
-0.070(-2.67%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.550
2.620
52 wk Range
2.520
8.970
ALBIO Scorecard
Full Analysis
Operates with a significant debt burden
High dividend Yield
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.5502.620
52 wk Range
2.5208.970
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(16.57%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(16.57%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockALBIO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Management has been aggressively buying back shares
Biosynex Company Profile
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women’s health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.
Compare ALBIO to Peers and Sector
Metrics to compare | ALBIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALBIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −1.0x | −0.7x | |
PEG Ratio | 0.31 | −0.03 | 0.00 | |
Price/Book | 0.3x | 2.0x | 2.6x | |
Price / LTM Sales | 0.3x | 2.7x | 3.2x | |
Upside (Analyst Target) | - | 112.9% | 44.5% | |
Fair Value Upside | Unlock | 7.1% | 6.6% | Unlock |
FAQ
What Is the Biosynex (ALBIO) Stock Price Today?
The Biosynex stock price today is 2.55
What Stock Exchange Does Biosynex Trade On?
Biosynex is listed and trades on the Paris stock exchange.
What Is the Stock Symbol for Biosynex?
The stock symbol for Biosynex is "ALBIO."
Does Biosynex Pay Dividends? What’s The Current Dividend Yield?
The Biosynex dividend yield is 16.57%.
What Is the Biosynex Market Cap?
As of today, Biosynex market cap is 27.44M.
What is Biosynex Earnings Per Share?
The Biosynex EPS is -3.47.
From a Technical Analysis Perspective, Is ALBIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.